Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, and Rosetta Genomics Ltd. (Nasdaq: ROSG), an innovative molecular diagnostic company, today announced the execution of ...

Addressing obviousness issues, the U. S. Court of Appeals for the Federal Circuit affirmed the district court’s invalidity conclusion, agreeing that the elements present in the prior art—including ...

@JohnCFierce: Derek Lowe explains in concise terms why BioTime's cell aging work has a long, long way to go. Item | Follow @JohnCFierce > Prometheus Laboratories struck a deal to collaborate with ...

The San Diego-based pharmaceutical company Prometheus Laboratories has launched PROMETHEUS Anser VDZ, a monitoring test for inflammatory bowel disease patients using vedolizumab. 1. The PROMETHEUS ...

Firm’s newly established business will use purchase to move into gastrointestinal testing. Nestlé’s recently established Nestlé Health Science operation will acquire specialty pharmaceutical and ...

In Prometheus Laboratories, Inc. v. Roxane Laboratories, Inc., [1] a recent decision involving methods of treating a specific subset of patients, the Court of Appeals for the Federal Circuit (“Federal ...

Prometheus Laboratories holds patents for how to determine the proper dosage of drugs that treat gastrointestinal and other autoimmune diseases. The problem for the company, defending itself Wednesday ...

SAN DIEGO, March 28, 2017 /PRNewswire/ -- Prometheus Laboratories Inc.—a Nestlé Health Science company—announces the launch of IBcause™, an all-in-one convenient test that evaluates a unique ...

NEW YORK, Nov 7 (Reuters) - Privately held Prometheus Laboratories Inc said on Wednesday it has agreed to acquire exclusive U.S. rights to GlaxoSmithKline's irritable bowel syndrome drug Lotronex.

Dec 19 (Reuters) - Prometheus Laboratories Inc filed with U.S. regulators on Wednesday to raise up to $100 million in an initial public offering of common stock. The San Diego, California-based ...